Skip to main content
. 2019 Feb 21;9:2513. doi: 10.1038/s41598-019-39221-2

Table 2.

Awareness, treatment and control of hypertension, dyslipidemia and obesity by glycemic status.

Items* Glycemic status
Normal glucose regulation (n, %) (n = 12765) Pre-diabetes (n,%) (n = 3641) Previously-diagnosed diabetes (n, %) (n = 1347) Newly-diagnosed diabetes (n %) (n = 609)
Hypertension Prevalence 3989 (31.2) 1621 (44.5) 840 (62.4) 339 (55.7)
Awareness 1793 (44.9) 693 (42.8) 578 (68.8) 169 (49.9)
Treatment 1503 (83.8) 569 (82.1) 510 (88.2) 143 (84.6)
Control 411 (27.3) 127 (22.3) 63 (12.4) 20 (14.0)
Dyslipidemia Prevalence 3959 (31.0) 1713 (47.0) 769 (57.1) 217 (35.6)
Awareness 395 (10.0) 119 (6.9) 140 (18.2) 37 (17.1)
Treatment 121 (30.6) 45 (37.8) 75 (53.6) 9 (24.3)
Control 6 (5.0) 2 (4.4) 3 (4.0) 0 (0)
Obesity Prevalence 1567 (12.3) 733 (20.1) 329 (24.4) 137 (22.5)
Awareness 1368 (87.3) 629 (85.8) 263 (79.9) 124 (90.5)
Treatment 439 (32.1) 196 (31.2) 79 (30.0) 34 (27.4)
Control 114 (26.0) 63 (32.1) 29 (36.7) 8 (23.5)

*“Awareness” refers to how many people in the total number of patients know their condition. “Treatment” refers to how many people who know their condition and take treatment measures. “Control” refers to how many of the people who have taken measures have been effectively controlled.